Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment Publisher



Arjmand B1, 2 ; Alavimoghadam S1 ; Khorsand G3 ; Sarvari M4 ; Arjmand R1 ; Rezaeitavirani M5 ; Rajaeinejad M6 ; Mosaed R2, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Student Research Committee, AJA University of Medical Sciences, Tehran, Iran
  3. 3. Iranian Cancer Control Center (MACSA), Tehran, Iran
  4. 4. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  6. 6. AJA Cancer Epidemiology Research and Treatment Center (AJA-CERTC), AJA University of Medical Sciences, Tehran, Iran
  7. 7. Toxicology Research Center, AJA University of Medical Sciences, Tehran, Iran

Source: Regenerative Engineering and Translational Medicine Published:2024


Abstract

Purpose: Cancer is now regarded as one of the significant public health concerns, and it is predicted to overtake cardiovascular diseases in 2060. Accordingly, there is a need for new, powerful medications to decrease the impact of cancer. Herein, metastatic tumors can be prevented or eliminated using preventative and therapeutic cancer vaccinations, especially cell-based types. However, further studies are needed in such a field. Therefore, the authors have reviewed the significance of cancer prevention, treatment, and management measures, particularly the use of cell-based vaccines. Methods: In order to find research on cell-based vaccinations and cancer therapies, we searched the literature using a combination of keywords to obtain publications published in PubMed, Scopus, and Web of Science between the years 2000 and 2023. Relevant and highly referenced articles were selected for this list. Results: In this review, we discuss the different types of cancer vaccines especially cell-based types. Further, we summarize related preclinical and clinical studies and also the ethical considerations. Present studies confirm the beneficial results of cell-based vaccines. Conclusion: Advancements of cancer management and immunotherapy have successfully elicited anti-cancer immune responses using chimeric antigen receptor (CAR)-T cells treatment, natural killer (NK) cell therapy, CAR-NK cell therapy, and cell-based vaccines. Lay Summary: Research has shown that powerful drugs are needed to decrease the consequences of cancer. In recent years, many types of immunotherapy have made considerable advancements in the treatment of cancer. These consist of NK cell treatment, CAR-NK cells, and CAR-T cell therapy. Recently, advancements in cancer vaccines, such as immunizations based on cells, have been made. Spreading cancers can now be totally prevented or halted thanks to prophylactic and cancer-specific vaccines. However, further research is needed to understand and progress in this area of treatment fully. © The Author(s), under exclusive licence to The Regenerative Engineering Society 2024.
Related Docs
View other Related Docs
1. Recent Advances in Regenerative Medicine Strategies for Cancer Treatment, Biomedicine and Pharmacotherapy (2021)
2. Crispr, Car-T, and Nk: Current Applications and Future Perspectives, Genes and Diseases (2024)
3. Car-Nk Cells: A Promising Cellular Immunotherapy in Lymphoma, Expert Opinion on Biological Therapy (2023)
4. Recent Progress in Cancer Immunotherapy: Overview of Current Status and Challenges, Pathology Research and Practice (2023)
5. Gene Therapy Clinical Trials, Where Do We Go? an Overview, Biomedicine and Pharmacotherapy (2022)
6. Gmp-Compliant Mesenchymal Stem Cell-Derived Exosomes for Cell-Free Therapy in Cancer, Methods in Molecular Biology (2024)
7. Combining Anti-Checkpoint Immunotherapies and Cancer Vaccines As a Novel Strategy in Oncological Therapy: A Review, Human Immunology (2025)
8. Breast Cancer Immunotherapy: Current and Novel Approaches, International Immunopharmacology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (18)
Babak Arjmand (10)
Other Related Docs
9. The Paths and Challenges of “Off-The-Shelf” Car-T Cell Therapy: An Overview of Clinical Trials, Biomedicine and Pharmacotherapy (2023)
10. Natural Killer Cell-Based Therapies in Neuroblastoma, Cellular Immunology (2025)
11. The Fingerprints of Biomedical Science in Internal Medicine, Advances in Experimental Medicine and Biology (2022)
12. Vaccination With Human Amniotic Epithelial Cells Confer Effective Protection in a Murine Model of Colon Adenocarcinoma, International Journal of Cancer (2018)
13. Car-Nk Cells for Haematological Cancers, Best Practice and Research: Clinical Haematology (2025)
14. Human Amniotic Epithelial Cells Exert Anti-Cancer Effects Through Secretion of Immunomodulatory Small Extracellular Vesicles (Sev), Cancer Cell International (2022)
15. Chimeric Antigen Receptor-Natural Killer Cells: A Promising Sword Against Insidious Tumor Cells, Human Cell (2023)
16. Induced Pluripotent Stem Cells: Generation Methods and a New Perspective in Covid-19 Research, Frontiers in Cell and Developmental Biology (2023)
17. A Novel Adc Targeting Cell Surface Fibromodulin in a Mouse Model of Triple-Negative Breast Cancer, Breast Cancer (2022)
18. Emerging Therapeutics and Delivery, Pharmaceutics: Basic Principles and Application to Pharmacy Practice# Second Edition (2023)
19. Biomimetic Nanotechnology for Cancer Immunotherapy: State of the Art and Future Perspective, International Journal of Pharmaceutics (2024)
20. Cancer Immunotherapy: Diverse Approaches and Obstacles, Current Pharmaceutical Design (2022)
21. Novel Gene Manipulation Approaches to Unlock the Existing Bottlenecks of Car-Nk Cell Therapy, Frontiers in Cell and Developmental Biology (2024)
22. Tumor Immunology, Clinical Immunology (2022)
23. Car-Nk Cell: A New Paradigm in Tumor Immunotherapy, Frontiers in Oncology (2021)
24. Clinical Potential of Pd-1/Pd-L1 Blockade Therapy for Renal Cell Carcinoma (Rcc): A Rapidly Evolving Strategy, Cancer Cell International (2022)
25. Cell and Cell-Derivative-Based Therapy for Liver Diseases: Current Approaches and Future Promises, Expert Review of Gastroenterology and Hepatology (2023)
26. Production of Car T-Cells by Gmp-Grade Lentiviral Vectors: Latest Advances and Future Prospects, Critical Reviews in Clinical Laboratory Sciences (2019)
27. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
28. Crispr-Cas9 in Basic and Translational Aspects of Cancer Therapy, BioImpacts (2024)
29. Immunohistochemistry of Cancers, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
30. Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019, Cancer Medicine (2023)
31. Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T Cells, Frontiers in Immunology (2018)
32. Mobile Applications in Breast Cancer Postoperative Care: A Scoping Review, Cancer Medicine (2024)
33. Smart Bio-Encapsulation for Immunotherapy, Smart Nanomaterials for Bioencapsulation (2022)
34. Machine Learning: A New Prospect in Multi-Omics Data Analysis of Cancer, Frontiers in Genetics (2022)
35. Immune Landscape of Hepatocellular Carcinoma: From Dysregulation of the Immune Responses to the Potential Immunotherapies, Cell Biochemistry and Function (2024)
36. Association of Imaging and Pathological Findings of Breast Cancer in Very Young Women: Report of a Twenty-Year Retrospective Study, Clinical Imaging (2024)
37. Nanotechnological Approaches in Prostate Cancer Therapy: Integration of Engineering and Biology, Nano Today (2022)
38. Immunotherapy of Cancers Comes of Age, Expert Review of Clinical Immunology (2017)
39. Targeted Drug Delivery Using Nanobodies to Deliver Effective Molecules to Breast Cancer Cells: The Most Attractive Application of Nanobodies, Cancer Cell International (2024)
40. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools, ACS Pharmacology and Translational Science (2023)
41. Crispr/Cas9 Revitalizes Adoptive T-Cell Therapy for Cancer Immunotherapy, Journal of Experimental and Clinical Cancer Research (2021)
42. Efficacy of Whole Cancer Stem Cell-Based Vaccines: A Systematic Review of Preclinical and Clinical Studies, Stem Cells (2023)
43. New Immunotherapy Approaches for Colorectal Cancer: Focusing on Car-T Cell, Bite, and Oncolytic Viruses, Cell Communication and Signaling (2024)
44. Immunovirotherapy: The Role of Antibody Based Therapeutics Combination With Oncolytic Viruses, Frontiers in Immunology (2022)
45. A Deep Insight Into Crispr/Cas9 Application in Car-T Cell-Based Tumor Immunotherapies, Stem Cell Research and Therapy (2021)
46. Investigating Socioeconomic Inequality in the Incidence of Breast Cancer in Iran: Interprovincial Analysis and Comparison, Scientific Journal of Kurdistan University of Medical Sciences (2025)
47. The Molecular Mechanism of Actions and Clinical Utilities of Tumor Infiltrating Lymphocytes in Gastrointestinal Cancers: A Comprehensive Review and Future Prospects Toward Personalized Medicine, Frontiers in Immunology (2023)
48. Induced Pluripotent Stem Cell Meets Severe Combined Immunodeficiency, Cell Journal (2020)
49. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
50. Human Placenta-Derived Mesenchymal Stem Cells Transplantation in Patients With Acute Respiratory Distress Syndrome (Ards) Caused by Covid-19 (Phase I Clinical Trial): Safety Profile Assessment, Stem Cell Research and Therapy (2022)